CLINICAL RESEARCH: CARDIAC IMAGING
Evaluation of Diffuse Myocardial Fibrosis in Heart Failure With Cardiac Magnetic Resonance Contrast-Enhanced T1 Mapping
Leah Iles, MBChB*,
Heinz Pfluger, MD*,
Arintaya Phrommintikul, MD*,
Joshi Cherayath, Dip AMIT ,
Pelin Aksit, MS ,
Sandeep N. Gupta, PhD ,
David M. Kaye, PhD* and
Andrew J. Taylor, PhD*,*
* Alfred Hospital and Baker IDI Heart and Diabetes Institute, Melbourne, Australia
GE Healthcare, Melbourne, Australia
Global Applied Science Laboratory, GE Healthcare, Bethesda, Maryland
Manuscript received February 13, 2008;
revised manuscript received May 8, 2008,
accepted June 10, 2008.
* Reprint requests and correspondence: Dr. Andrew J. Taylor, Alfred Hospital and Baker IDI Heart and Diabetes Institute, Heart Centre, Alfred Hospital, Commercial Road, Melbourne 3004, Australia (Email: andrew.taylor{at}bakeridi.edu.au).
Objectives: The purpose of this study was to investigate a noninvasive method for quantifying diffuse myocardial fibrosis with cardiac magnetic resonance imaging (CMRI).
Background: Diffuse myocardial fibrosis is a fundamental process in pathologic remodeling in cardiomyopathy and is postulated to cause increased cardiac stiffness and poor clinical outcomes. Although regional fibrosis is easily imaged with cardiac magnetic resonance, there is currently no noninvasive method for quantifying diffuse myocardial fibrosis.
Methods: We performed CMRI on 45 subjects (25 patients with heart failure, 20 control patients), on a clinical 1.5-T CMRI scanner. A prototype T1 mapping sequence was used to calculate the post-contrast myocardial T1 time as an index of diffuse fibrosis; regional fibrosis was identified by delayed contrast enhancement. Regional and global systolic function was assessed by cine CMRI in standard short- and long-axis planes, with echocardiography used to evaluate diastology. An additional 9 subjects underwent CMRI and endomyocardial biopsy for histologic correlation.
Results: Post-contrast myocardial T1 times correlated histologically with fibrosis (R = –0.7, p = 0.03) and were shorter in heart failure subjects than controls (383 ± 17 ms vs. 564 ± 23 ms, p < 0.0001). The T1 time of heart failure myocardium was shorter than that in controls even when excluding areas of regional fibrosis (429 ± 22 ms vs. 564 ± 23 ms, p < 0.0001). The post-contrast myocardial T1 time shortened as diastolic function worsened (562 ± 24 ms in normal diastolic function vs. 423 ± 33 ms in impaired diastolic function vs. 368 ± 20 ms in restrictive function, p < 0.001).
Conclusions: Contrast-enhanced CMRI T1 mapping identifies changes in myocardial T1 times in heart failure, which appear to reflect diffuse fibrosis.
Key Words: cardiac magnetic resonance imaging fibrosis heart failure cardiomyopathy
|
Abbreviations and Acronyms
| | CCF = congestive cardiac failure | | CMRI = cardiac magnetic resonance imaging | | DE– = myocardium without delayed enhancement | | DE+ = myocardium with delayed enhancement | | ECG = electrocardiogram | | GFR = glomerular filtration rate | | ICMP = ischemic cardiomyopathy | | IDCM = idiopathic dilated cardiomyopathy | | LVEF = left ventricular ejection fraction | | ROI = region of interest | | TTE = transthoracic echocardiography |
|
Related Articles
-
There Is More Than Shape and Function
- Matthias G. Friedrich
J. Am. Coll. Cardiol. 2008 52: 1581-1583.
[Full Text]
[PDF]
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A40.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. Ugander, A. J. Oki, L.-Y. Hsu, P. Kellman, A. Greiser, A. H. Aletras, C. T. Sibley, M. Y. Chen, W. P. Bandettini, and A. E. Arai
Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology
Eur. Heart J.,
January 24, 2012;
(2012)
ehr481v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. T. Ng, D. Auger, V. Delgado, S. G. C. van Elderen, M. Bertini, H.-M. Siebelink, R. J. van der Geest, C. Bonetti, E. T. van der Velde, A. de Roos, et al.
Association Between Diffuse Myocardial Fibrosis by Cardiac Magnetic Resonance Contrast-Enhanced T1 Mapping and Subclinical Myocardial Dysfunction in Diabetic Patients: A Pilot Study
Circ Cardiovasc Imaging,
January 1, 2012;
5(1):
51 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. La Gerche, A. T. Burns, D. J. Mooney, W. J. Inder, A. J. Taylor, J. Bogaert, A. I. MacIsaac, H. Heidbuchel, and D. L. Prior
Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes
Eur. Heart J.,
December 6, 2011;
(2011)
ehr397v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Bax and V. Delgado
Prediction of individual response to heart failure therapy
Eur. Heart J.,
November 21, 2011;
(2011)
ehr416v1.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Leong, A. Chakrabarty, N. Shipp, P. Molaee, P. L. Madsen, L. Joerg, T. Sullivan, S. G. Worthley, C. G. De Pasquale, P. Sanders, et al.
Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography
Eur. Heart J.,
November 1, 2011;
(2011)
ehr391v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Ordovas and C. B. Higgins
Delayed Contrast Enhancement on MR Images of Myocardium: Past, Present, Future
Radiology,
November 1, 2011;
261(2):
358 - 374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Messroghli, S. Nordmeyer, T. Dietrich, O. Dirsch, E. Kaschina, K. Savvatis, D. O h-Ici, C. Klein, F. Berger, and T. Kuehne
Assessment of Diffuse Myocardial Fibrosis in Rats Using Small-Animal Look-Locker Inversion Recovery T1 Mapping
Circ Cardiovasc Imaging,
November 1, 2011;
4(6):
636 - 640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Jellis, J. Wright, D. Kennedy, J. Sacre, C. Jenkins, B. Haluska, J. Martin, J. Fenwick, and T. H. Marwick
Association of Imaging Markers of Myocardial Fibrosis With Metabolic and Functional Disturbances in Early Diabetic Cardiomyopathy
Circ Cardiovasc Imaging,
November 1, 2011;
4(6):
693 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Dweck, S. Joshi, T. Murigu, F. Alpendurada, A. Jabbour, G. Melina, W. Banya, A. Gulati, I. Roussin, S. Raza, et al.
Midwall Fibrosis Is an Independent Predictor of Mortality in Patients With Aortic Stenosis
J. Am. Coll. Cardiol.,
September 13, 2011;
58(12):
1271 - 1279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nazarian
Is Ventricular Arrhythmia a Possible Mediator of the Association Between Aortic Stenosis-Related Midwall Fibrosis and Mortality?
J. Am. Coll. Cardiol.,
September 13, 2011;
58(12):
1280 - 1282.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Iles, H. Pfluger, L. Lefkovits, M. J. Butler, P. M. Kistler, D. M. Kaye, and A. J. Taylor
Reply
J. Am. Coll. Cardiol.,
September 6, 2011;
58(11):
1194 - 1195.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Karamitsos and S. Neubauer
The interplay between cardiac strain and fibrosis in non-ischaemic cardiomyopathies: insights from cardiovascular magnetic resonance
Eur J Heart Fail,
September 1, 2011;
13(9):
927 - 928.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. AlJaroudi, J. Chen, W. A. Jaber, S. G. Lloyd, M. D. Cerqueira, and T. Marwick
Nonechocardiographic Imaging in Evaluation for Cardiac Resynchronization Therapy
Circ Cardiovasc Imaging,
May 1, 2011;
4(3):
334 - 343.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lehrke, D. Lossnitzer, M. Schob, H. Steen, C. Merten, H. Kemmling, R. Pribe, P. Ehlermann, C. Zugck, G. Korosoglou, et al.
Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy
Heart,
May 1, 2011;
97(9):
727 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mewton, C. Y. Liu, P. Croisille, D. Bluemke, and J. A. C. Lima
Assessment of Myocardial Fibrosis With Cardiovascular Magnetic Resonance
J. Am. Coll. Cardiol.,
February 22, 2011;
57(8):
891 - 903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Iles, H. Pfluger, L. Lefkovits, M. J. Butler, P. M. Kistler, D. M. Kaye, and A. J. Taylor
Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death
J. Am. Coll. Cardiol.,
February 15, 2011;
57(7):
821 - 828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Leong, P. L. Madsen, and J. B. Selvanayagam
Non-invasive evaluation of myocardial fibrosis: implications for the clinician
Heart,
December 15, 2010;
96(24):
2016 - 2024.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Broberg, S. S. Chugh, C. Conklin, D. J. Sahn, and M. Jerosch-Herold
Quantification of Diffuse Myocardial Fibrosis and Its Association With Myocardial Dysfunction in Congenital Heart Disease
Circ Cardiovasc Imaging,
November 1, 2010;
3(6):
727 - 734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Azevedo, M. Nigri, M. L. Higuchi, P. M. Pomerantzeff, G. S. Spina, R. O. Sampaio, F. Tarasoutchi, M. Grinberg, and C. E. Rochitte
Prognostic Significance of Myocardial Fibrosis Quantification by Histopathology and Magnetic Resonance Imaging in Patients With Severe Aortic Valve Disease
J. Am. Coll. Cardiol.,
July 20, 2010;
56(4):
278 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Kramer
Cardiac Magnetic Resonance Imaging Identification of Myocardial Fibrosis: The Need for Standardization and Therapies
J. Am. Coll. Cardiol.,
July 20, 2010;
56(4):
288 - 289.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Jellis, J. Martin, J. Narula, and T. H. Marwick
Assessment of Nonischemic Myocardial Fibrosis
J. Am. Coll. Cardiol.,
July 6, 2010;
56(2):
89 - 97.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Slaughter and P. M. Mottram
What Should Be the Principle Imaging Test in Heart Failure--CMR or Echocardiography?
J. Am. Coll. Cardiol. Img.,
July 1, 2010;
3(7):
776 - 782.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lopez, A. Gonzalez, and J. Diez
Circulating Biomarkers of Collagen Metabolism in Cardiac Diseases
Circulation,
April 13, 2010;
121(14):
1645 - 1654.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Leong, C. G. De Pasquale, and J. B. Selvanayagam
Heart Failure With Normal Ejection Fraction: The Complementary Roles of Echocardiography and CMR Imaging
J. Am. Coll. Cardiol. Img.,
April 1, 2010;
3(4):
409 - 420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Marwick, S. V. Raman, I. Carrio, and J. J. Bax
Recent Developments in Heart Failure Imaging
J. Am. Coll. Cardiol. Img.,
April 1, 2010;
3(4):
429 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sueyoshi, I. Sakamoto, and M. Uetani
Contrast-Enhanced Myocardial Inversion Time at the Null Point for Detection of Left Ventricular Myocardial Fibrosis in Patients With Dilated and Hypertrophic Cardiomyopathy: A Pilot Study
Am. J. Roentgenol.,
April 1, 2010;
194(4):
W293 - W298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Raman
The Hypertensive Heart: An Integrated Understanding Informed by Imaging
J. Am. Coll. Cardiol.,
January 12, 2010;
55(2):
91 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bertini, V. Delgado, D. W. den Uijl, G. Nucifora, A. C.T. Ng, R. J. van Bommel, C. J. W. Borleffs, G. Boriani, M. J. Schalij, and J. J. Bax
Prediction of Cardiac Resynchronization Therapy Response: Value of Calibrated Integrated Backscatter Imaging
Circ Cardiovasc Imaging,
January 1, 2010;
3(1):
86 - 93.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Diez and E. D. Frohlich
A Translational Approach to Hypertensive Heart Disease
Hypertension,
January 1, 2010;
55(1):
1 - 8.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Karamitsos, J. M. Francis, S. Myerson, J. B. Selvanayagam, and S. Neubauer
The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure
J. Am. Coll. Cardiol.,
October 6, 2009;
54(15):
1407 - 1424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Mousseaux
Obesity and Cardiovascular Disease: How Can Cardiac Magnetic Resonance Help?
J. Am. Coll. Cardiol.,
August 18, 2009;
54(8):
727 - 729.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al.
Highlights of the Year in JACC 2008
J. Am. Coll. Cardiol.,
January 27, 2009;
53(4):
373 - 398.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Friedrich
There Is More Than Shape and Function
J. Am. Coll. Cardiol.,
November 4, 2008;
52(19):
1581 - 1583.
[Full Text]
[PDF]
|
 |
|
|